Pregled bibliografske jedinice broj: 22699
Toxicity of amylin from sera of NIDDM patients on isolated islet cells
Toxicity of amylin from sera of NIDDM patients on isolated islet cells // XIIth IFCC European Congress of Clinical Chemistry (MEDLAB 97) : abstrasts
Basel, 1997. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 22699 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Toxicity of amylin from sera of NIDDM patients on isolated islet cells
Autori
Šupe, Daniela ; Juretić, Dubravka ; Hadžija, Mirko ; Rumora, Lada ; Pavić-Renar, Ivana ; Slijepčević, Milivoj
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
XIIth IFCC European Congress of Clinical Chemistry (MEDLAB 97) : abstrasts
/ - Basel, 1997
Skup
IFCC European Congress of Clinical Chemistry (12 ; 1997)
Mjesto i datum
Basel, Švicarska, 17.08.1997. - 22.08.1997
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
diabetes; Langerhans islets; sera; apoptosis; collagenase
Sažetak
Diabetes type II is accompanied by an elevated serum amylin. This paptide was shown to be cytotoxic to rat insulinoma islet beta-cells in tissue culture, through a mechanism which includes DNA damage and apoptosis. We have investigated the ability of diabetic patients sera to cause beta-cell death by a similar mechanism. Islets of Langerhans were isolated from rat pancreas by collagenase digestion and subsequently treated with sera of type II diabetic patients by incubation for 48 hours at 22oC. Viable cell count and nucleus fragmentation was determined by propidium iodide staining and fluorescent microscopy. Isolated rat Langerhans islets treated with sera from diabetic patients with hyperinsulinemia, have shown reduced viability of beta-cells, and morphological characteristics of apoptotic process. DNA fragmentation in islet beta-cells was also demonstrated. Control human sera, even at higher concentrations, did not cause the same effect. These findings identify DNA as an early target of "amylin" present in sera of diabetes type II patients with hyperglycaemia and hyperinsulinemia. Amylin from sera of diabetes type II patients is a likely candidate for a factor which enhances nucleus fragmentation, apoptosis and reduction of islet beta-cell population in vivo.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb
Profili:
Dubravka Juretić
(autor)
Milivoj Slijepčević
(autor)
Lada Rumora
(autor)
Ivana Pavlić-Renar
(autor)
Mirko Hadžija
(autor)